Paris - Delayed Quote EUR

TME Pharma N.V. (ALTME.PA)

0.0720
-0.0005
(-0.69%)
As of 4:53:16 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
5,258
5,258
5,624
11,996
13,451
Operating Income
-5,258
-5,258
-5,624
-11,996
-13,451
Net Non Operating Interest Income Expense
-471
-471
-1,119
-3,097
-1,185
Pretax Income
-5,722
-5,722
-6,734
-15,126
-14,452
Tax Provision
0
0
2
7
1
Net Income Common Stockholders
-5,722
-5,722
-6,736
-15,132
-14,452
Diluted NI Available to Com Stockholders
-5,722
-5,722
-6,736
-15,132
-14,452
Basic EPS
-0.12
-0.12
-1.00
-9.59
-14.80
Diluted EPS
-0.12
-0.12
-1.00
-9.59
-14.80
Basic Average Shares
48,250.4630
48,250.4630
6,729.8630
1,577.4880
976.1540
Diluted Average Shares
48,250.4630
48,250.4630
6,729.8630
1,577.4880
976.1540
Total Operating Income as Reported
-5,251
-5,251
-5,615
-12,029
-13,267
Total Expenses
5,258
5,258
5,624
11,996
13,451
Net Income from Continuing & Discontinued Operation
-5,722
-5,722
-6,736
-15,132
-14,452
Normalized Income
-5,722
-5,722
-6,736
-15,132
-14,452
Interest Income
32
32
399
303
319
Interest Expense
503
503
1,518
3,400
1,504
Net Interest Income
-471
-471
-1,119
-3,097
-1,185
EBIT
-5,219
-5,219
-5,216
-11,726
-12,948
EBITDA
-5,141
-5,141
-5,072
-11,634
-12,882
Reconciled Depreciation
78
78
144
92
66
Net Income from Continuing Operation Net Minority Interest
-5,722
-5,722
-6,736
-15,132
-14,452
Normalized EBITDA
-5,141
-5,141
-5,072
-11,634
-12,882
Tax Rate for Calcs
0
0
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IDIAz.XC
 
VSC.F 4SC AG
3.2100
-13.24%
 
HPHA.DE Heidelberg Pharma AG
3.2300
0.00%
 
VVY.AS Vivoryon Therapeutics N.V.
1.7580
+1.99%
 
ALGAE.PA FERMENTALG
0.5930
+0.17%
 
NYKD.OL Nykode Therapeutics AS
2.6860
+0.30%
 
ALCLS.PA Cellectis S.A.
1.3540
-0.29%
 
ALNEV.PA Neovacs S.A.
0.0050
-19.35%
 
VICO.ST Vicore Pharma Holding AB (publ)
7.91
-7.38%
 
ATORX.ST Alligator Bioscience AB (publ)
4.2000
+5.18%